Ladies and gentlemen, good afternoon and welcome to the Clover Health Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A ...

Healthcare solutions provider Solventum (NYSE:SOLV) reported in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion.

Ather Energy expands R&D capabilities, discusses investments, market expansion, product development, and EV industry trends ...

Another major risk comes from Shenzhou’s heavy reliance on a concentrated customer base. Nike, Adidas, and Uniqlo collectively contributed about 70% of total revenue. This high dependency poses a risk ...

Top-line data from Phase 2b IMPACT trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH) to be reported in Q2 ...

The move was 'absolutely to keep a rein on costs and drive towards being cash flow positive' CEO Tim Steiner said ...

Ocado is set to reduce its research and development workforce both in the UK and globally in a bid to return to profitability ...

Read here to understand EV adoption in India, key challenges, and how CarDekho helps customers with complete insights, ...

SINGAPORE will launch an applied artificial intelligence (AI) initiative and two kinds of large-scale, cross-cutting programmes in its next five-year Research, Innovation, and Enterprise (RIE) plan, ...

Dual-listed biotech Mesoblast extended its loss in the first half to US$47.9 million ($75.9 million) as revenue lowered year ...

University research has developed a "bad look" – its overhead rates seem excessive and out of line with other benchmarks – ...

India is known as the ‘pharmacy of the world,’ dominating generic drug manufacturing. But now, the country is moving up the ...